Prud’homme, Dan and Tong, Tony W. 2024. Rethinking firm-specific advantages from intellectual property rights: Boundary conditions for MNEs. Journal of International Business Studies, Vol. 55, Issue.
Arvinas, Inc. (Nasdaq: ARVN) today announced that three posters for vepdegestrant, including clinical data, will be presented (SABCS), being held December 10-13, 2024, in San Antonio, Texas.
Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced it ...
However, the landscape of innovation is increasingly shaped by intellectual property (IP) laws—government interventions ostensibly designed to protect and incentivize creativity, but which often end ...
Penn State has won a closely watched trademark fight over an online retailer’s use of its vintage logos and images The Latest A federal judge has ordered the Port of Oakland to stop using San ...